# A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors

> **NCT05678283** · PHASE1 · WITHDRAWN · sponsor: **Bristol-Myers Squibb**

## Conditions studied

- Advanced Solid Tumors

## Interventions

- **DRUG:** [14C]CC-90010
- **DRUG:** CC-90010

## Key facts

- **NCT ID:** NCT05678283
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-01-09
- **Primary completion:** 2024-04-29
- **Final completion:** 2024-04-29
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** Business Objectives have changed.
- **Last updated:** 2024-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05678283

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05678283, "A Study of Absorption, Metabolism, and Elimination CC-90010 in Participants With Advanced Solid Tumors". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT05678283. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*